Advanced Renal Cell Carcinoma: Patient-Specific Recommendations From an International Panel of Experts

Gain global perspective on the treatment of advanced RCC in this comprehensive educational program. Evaluate your choice of therapy against a panel of international experts with an Interactive Decision Support Tool or read through the CME-certified module and ClinicalThought commentary to review strategies for individualized first-line and second-line treatment, the available sequencing treatment, and adverse event management.
Bernard Escudier, MD
person default
James Larkin, PhD, FRCP
Bradley A. McGregor, MD
person default
Michael Staehler, MD, PhD
Cora N. Sternberg, MD, FACP


Even prior to approval, new data from cabozantinib and combination PD-L1 and CTLA-4 inhibition are transforming treatment of metastatic RCC.

Bradley A. McGregor, MD Released: November 9, 2017

Interactive Decision Support Tool

This interactive treatment decision aid will let you compare your choice of therapy for patients with advanced RCC with expert recommendations from Bernard Escudier, MD; Bradley A. McGregor, MD; James M. G. Larkin, MD, PhD; Michael Staehler, MD, PhD; and Cora N. Sternberg, MD, FACP. 

Bernard Escudier, MD person default James Larkin, PhD, FRCP Bradley A. McGregor, MD person default Michael Staehler, MD, PhD Cora N. Sternberg, MD, FACP Released: December 1, 2017


Bradley A. McGregor, MD, reviews and summarizes country- and patient-specific treatment recommendations from an international panel of experts based on recent practice-changing clinical trial results in RCC.

Bradley A. McGregor, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: February 27, 2018 Expired: February 26, 2019

Downloadable Slideset

In this downloadable slideset, Bradley A. McGregor, MD, discusses the optimal treatment approaches and management options for patients with advanced RCC from an international perspective.

Released: February 27, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an educational grant from
Ipsen Biopharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?